HRS 4800
Alternative Names: HRS-4800Latest Information Update: 28 Oct 2024
Price :
$50 *
At a glance
- Originator Atridia
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Pain
Most Recent Events
- 28 Oct 2024 No recent reports of development identified for phase-I development in Pain(In volunteers) in China (PO, Tablet)
- 28 Dec 2023 No recent reports of development identified for phase-I development in Pain(In volunteers) in Australia (PO, Tablet)
- 22 Mar 2022 Jiangsu HengRui Medicine completes a phase IIa trial in Pain in China (NCT05318846)